Lead Product(s) : Ephedrine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Nevakar Announces FDA Approval for Ephedrine Sulfate Injection as Ready-To-Use Vials
Details : Nevakar received approval from the FDA to market Ephedrine Sulfate Injection in a ready- to-use 50mg/10 ml single use vial presentation.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 22, 2020
Lead Product(s) : Ephedrine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ephedrine
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Baker Heart and Diabetes Institute | The Alfred
Deal Size : Inapplicable
Deal Type : Inapplicable
Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 11, 2014
Lead Product(s) : Ephedrine
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Baker Heart and Diabetes Institute | The Alfred
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ephedrine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Prophylactic Ephedrine and Combined Spinal Epidurals for Labor
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 14, 2014
Lead Product(s) : Ephedrine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
